{"id":"https://openalex.org/W4416691663","doi":"https://doi.org/10.1038/s41698-025-01179-y","title":"Combination therapy overcomes secondary PARPi resistance in ATM-deficient prostate cancer","display_name":"Combination therapy overcomes secondary PARPi resistance in ATM-deficient prostate cancer","publication_year":2025,"publication_date":"2025-11-26","ids":{"openalex":"https://openalex.org/W4416691663","doi":"https://doi.org/10.1038/s41698-025-01179-y","pmid":"https://pubmed.ncbi.nlm.nih.gov/41299058"},"language":"en","primary_location":{"id":"doi:10.1038/s41698-025-01179-y","doi":"https://doi.org/10.1038/s41698-025-01179-y","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41698-025-01179-y","pdf_url":"https://www.nature.com/articles/s41698-025-01179-y_reference.pdf","source":{"id":"https://openalex.org/S4210211538","display_name":"npj Precision Oncology","issn_l":"2397-768X","issn":["2397-768X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"npj Precision Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.nature.com/articles/s41698-025-01179-y_reference.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084757792","display_name":"Sara Arce\u2010Gallego","orcid":"https://orcid.org/0009-0009-7294-0011","observed_orcids":["https://orcid.org/0009-0009-7294-0011"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Sara Arce-Gallego","raw_affiliation_strings":["Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117258341","display_name":"Victor Esquefa","orcid":"https://orcid.org/0009-0004-3944-0203","observed_orcids":["https://orcid.org/0009-0004-3944-0203"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Victor Esquefa","raw_affiliation_strings":["Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092414402","display_name":"Heura Dom\u00e8nech","orcid":"https://orcid.org/0009-0002-8187-7455","observed_orcids":["https://orcid.org/0009-0002-8187-7455"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Heura Domenech","raw_affiliation_strings":["Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, Barcelona, Spain","Experimental Therapeutics, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I123044942"]},{"raw_affiliation_string":"Experimental Therapeutics, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5098729781","display_name":"Andrei Salca","orcid":"https://orcid.org/0009-0007-3813-0299","observed_orcids":["https://orcid.org/0009-0007-3813-0299"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Andrei Salca","raw_affiliation_strings":["Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041954629","display_name":"Daniel Aguilar","orcid":"https://orcid.org/0000-0001-7520-4508","observed_orcids":["https://orcid.org/0000-0001-7520-4508","https://orcid.org/0000-0001-5399-3278"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Daniel Aguilar","raw_affiliation_strings":["Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120534135","display_name":"Teresa Casals","orcid":"https://orcid.org/0009-0000-9173-6387","observed_orcids":["https://orcid.org/0009-0000-9173-6387"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Teresa Casals","raw_affiliation_strings":["Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008268293","display_name":"Gisela Mir Arnau","orcid":"https://orcid.org/0000-0002-9005-3485","observed_orcids":["https://orcid.org/0000-0002-9005-3485"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Gisela Mir","raw_affiliation_strings":["Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058879283","display_name":"Sara Simonetti","orcid":"https://orcid.org/0000-0003-2406-030X","observed_orcids":["https://orcid.org/0000-0003-2406-030X"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Sara Simonetti","raw_affiliation_strings":["Molecular Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078244510","display_name":"Anna Oliveira","orcid":"https://orcid.org/0009-0004-6872-1311","observed_orcids":["https://orcid.org/0009-0004-6872-1311"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Anna Oliveira","raw_affiliation_strings":["Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050990472","display_name":"Lara de Llobet","orcid":"https://orcid.org/0000-0001-6249-7276","observed_orcids":["https://orcid.org/0000-0001-6249-7276"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Lara de Llobet","raw_affiliation_strings":["Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026608126","display_name":"Antje Neeb","orcid":"https://orcid.org/0000-0002-6516-2938","observed_orcids":["https://orcid.org/0000-0002-6516-2938"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Antje Neeb","raw_affiliation_strings":["The Institute of Cancer Research and The Royal Marsden NHS Trust, Sutton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research and The Royal Marsden NHS Trust, Sutton, UK","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039666943","display_name":"Julian Brandariz","orcid":"https://orcid.org/0009-0006-4316-3952","observed_orcids":["https://orcid.org/0009-0006-4316-3952"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Julian Brandariz","raw_affiliation_strings":["Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018417654","display_name":"Nicol\u00e1s Anselmino","orcid":"https://orcid.org/0000-0002-6482-2623","observed_orcids":["https://orcid.org/0000-0002-6482-2623"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Nicolas Anselmino","raw_affiliation_strings":["Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065565553","display_name":"Irene Casanova\u2010Salas","orcid":"https://orcid.org/0000-0002-0499-1038","observed_orcids":["https://orcid.org/0000-0002-0499-1038"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Irene Casanova-Salas","raw_affiliation_strings":["Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075209115","display_name":"Nicol\u00e1s Herranz","orcid":"https://orcid.org/0000-0003-1351-7300","observed_orcids":["https://orcid.org/0000-0003-1351-7300"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Nicolas Herranz","raw_affiliation_strings":["Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073423716","display_name":"Violeta Serra","orcid":"https://orcid.org/0000-0001-6620-1065","observed_orcids":["https://orcid.org/0000-0001-6620-1065"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Violeta Serra","raw_affiliation_strings":["Experimental Therapeutics, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Johann S. de Bono","raw_affiliation_strings":["The Institute of Cancer Research and The Royal Marsden NHS Trust, Sutton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research and The Royal Marsden NHS Trust, Sutton, UK","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037380661","display_name":"Joaqu\u0131\u0301n Mateo","orcid":"https://orcid.org/0000-0001-5336-2548","observed_orcids":["https://orcid.org/0000-0001-5336-2548"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Joaquin Mateo","raw_affiliation_strings":["Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. jmateo@vhio.net","Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain. jmateo@vhio.net","Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. jmateo@vhio.net","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]},{"raw_affiliation_string":"Prostate Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain. jmateo@vhio.net","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]},{"raw_affiliation_string":"Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5037380661"],"corresponding_institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"],"apc_list":{"value":4090,"currency":"USD","value_usd":4090},"apc_paid":{"value":4090,"currency":"USD","value_usd":4090},"fwci":1.4419,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.8449852,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"9","issue":"1","first_page":"407","last_page":"407"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8899999856948853},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.7990000247955322},{"id":"https://openalex.org/keywords/atm-deficiency","display_name":"ATM deficiency","score":0.9290000200271606},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9010000228881836},{"id":"https://openalex.org/keywords/atr-chk1-signaling","display_name":"ATR-Chk1 signaling","score":0.6439999938011169},{"id":"https://openalex.org/keywords/replication-stress","display_name":"replication stress","score":0.8799999952316284},{"id":"https://openalex.org/keywords/g2-m-checkpoint","display_name":"G2/M checkpoint","score":0.6570000052452087},{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.9160000085830688},{"id":"https://openalex.org/keywords/parp1-inhibitors","display_name":"PARP-1 inhibitors","score":0.6439999938011169},{"id":"https://openalex.org/keywords/homologous-recombination-repair","display_name":"homologous recombination repair","score":0.8299999833106995},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.828000009059906},{"id":"https://openalex.org/keywords/metastatic-prostate-cancer","display_name":"metastatic prostate cancer","score":0.7409999966621399}],"concepts":[{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.8392999768257141},{"id":"https://openalex.org/C2778480876","wikidata":"https://www.wikidata.org/wiki/Q21112674","display_name":"PARP1","level":5,"score":0.7724000215530396},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7250999808311462},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6929000020027161},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.6517000198364258},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.5813000202178955},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5532000064849854},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.49070000648498535},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.460099995136261},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41370001435279846},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3718000054359436},{"id":"https://openalex.org/C102744134","wikidata":"https://www.wikidata.org/wiki/Q22280388","display_name":"Homologous recombination","level":3,"score":0.35679998993873596},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34470000863075256},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.33000001311302185},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.3296999931335449},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.32339999079704285},{"id":"https://openalex.org/C2778502085","wikidata":"https://www.wikidata.org/wiki/Q7662767","display_name":"Synthetic lethality","level":4,"score":0.3192000091075897},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.31209999322891235},{"id":"https://openalex.org/C2994294914","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired resistance","level":3,"score":0.31189998984336853},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.2761000096797943},{"id":"https://openalex.org/C2107291","wikidata":"https://www.wikidata.org/wiki/Q14886885","display_name":"Mediator","level":2,"score":0.2612000107765198}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1038/s41698-025-01179-y","doi":"https://doi.org/10.1038/s41698-025-01179-y","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41698-025-01179-y","pdf_url":"https://www.nature.com/articles/s41698-025-01179-y_reference.pdf","source":{"id":"https://openalex.org/S4210211538","display_name":"npj Precision Oncology","issn_l":"2397-768X","issn":["2397-768X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"npj Precision Oncology","raw_type":"journal-article"},{"id":"pmid:41299058","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41299058","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"NPJ precision oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:98f3b5c692644601b70fbe80a8b1794d","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/98f3b5c692644601b70fbe80a8b1794d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"npj Precision Oncology, Vol 9, Iss 1, Pp 1-10 (2025)","raw_type":"article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12750001","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12750001/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"NPJ Precis Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1038/s41698-025-01179-y","doi":"https://doi.org/10.1038/s41698-025-01179-y","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41698-025-01179-y","pdf_url":"https://www.nature.com/articles/s41698-025-01179-y_reference.pdf","source":{"id":"https://openalex.org/S4210211538","display_name":"npj Precision Oncology","issn_l":"2397-768X","issn":["2397-768X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"npj Precision Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[{"id":"https://openalex.org/G1285239955","display_name":null,"funder_award_id":"ERAPERMED2019-215","funder_id":"https://openalex.org/F4320307770","funder_display_name":"AstraZeneca"},{"id":"https://openalex.org/G1586042237","display_name":null,"funder_award_id":"FI19/00280","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G2262748287","display_name":null,"funder_award_id":"501100011033","funder_id":"https://openalex.org/F4320335598","funder_display_name":"Agencia Estatal de Investigaci\u00f3n"},{"id":"https://openalex.org/G3005324705","display_name":null,"funder_award_id":"501100011033","funder_id":"https://openalex.org/F4320321505","funder_display_name":"Generalitat de Catalunya"},{"id":"https://openalex.org/G3480869486","display_name":null,"funder_award_id":"13039","funder_id":"https://openalex.org/F4320335598","funder_display_name":"Agencia Estatal de Investigaci\u00f3n"},{"id":"https://openalex.org/G42267951","display_name":null,"funder_award_id":"24YOU12","funder_id":"https://openalex.org/F4320306163","funder_display_name":"Prostate Cancer Foundation"},{"id":"https://openalex.org/G425668148","display_name":null,"funder_award_id":".13039/501100011033","funder_id":"https://openalex.org/F4320335598","funder_display_name":"Agencia Estatal de Investigaci\u00f3n"},{"id":"https://openalex.org/G6656126374","display_name":null,"funder_award_id":"501100011033","funder_id":"https://openalex.org/F4320315803","funder_display_name":"Centres de Recerca de Catalunya"},{"id":"https://openalex.org/G7084143925","display_name":null,"funder_award_id":"AEI/10","funder_id":"https://openalex.org/F4320335598","funder_display_name":"Agencia Estatal de Investigaci\u00f3n"}],"funders":[{"id":"https://openalex.org/F4320306163","display_name":"Prostate Cancer Foundation","ror":"https://ror.org/01npwtv09"},{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320310210","display_name":"Fundaci\u00f3n Cellex","ror":"https://ror.org/019dmpq73"},{"id":"https://openalex.org/F4320315803","display_name":"Centres de Recerca de Catalunya","ror":"https://ror.org/01bkbaq61"},{"id":"https://openalex.org/F4320319264","display_name":"MacroGenics","ror":"https://ror.org/01hcd4187"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320321411","display_name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","ror":"https://ror.org/00gxct719"},{"id":"https://openalex.org/F4320321505","display_name":"Generalitat de Catalunya","ror":"https://ror.org/01bg62x04"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320325394","display_name":"Ministry of Minority Affairs","ror":"https://ror.org/050kded90"},{"id":"https://openalex.org/F4320328062","display_name":"MorphoSys","ror":"https://ror.org/00ew7rg06"},{"id":"https://openalex.org/F4320332150","display_name":"CRIS Cancer Foundation","ror":"https://ror.org/05qdgvk25"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320334923","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886"},{"id":"https://openalex.org/F4320335598","display_name":"Agencia Estatal de Investigaci\u00f3n","ror":"https://ror.org/003x0zc53"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4416691663.pdf","grobid_xml":"https://content.openalex.org/works/W4416691663.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W2022529631","https://openalex.org/W2036897871","https://openalex.org/W2103146352","https://openalex.org/W2138207763","https://openalex.org/W2146512944","https://openalex.org/W2169456326","https://openalex.org/W2594301310","https://openalex.org/W2607665721","https://openalex.org/W2765281411","https://openalex.org/W2810748925","https://openalex.org/W2898088739","https://openalex.org/W2973954290","https://openalex.org/W3003159103","https://openalex.org/W3008060424","https://openalex.org/W3009259386","https://openalex.org/W3020771563","https://openalex.org/W3043828603","https://openalex.org/W3084114043","https://openalex.org/W3099862724","https://openalex.org/W3102253437","https://openalex.org/W3165176963","https://openalex.org/W3176275742","https://openalex.org/W4210270885","https://openalex.org/W4289951438","https://openalex.org/W4291016626","https://openalex.org/W4316804884","https://openalex.org/W4388539829","https://openalex.org/W4388901979","https://openalex.org/W4395468216","https://openalex.org/W4404588077"],"related_works":[],"abstract_inverted_index":{"PARP":[0],"inhibitors":[1],"(PARPi)":[2],"are":[3,20],"approved":[4],"treatments":[5],"for":[6],"patients":[7],"with":[8,14,34],"metastatic":[9],"prostate":[10,65],"cancer":[11,66],"(mPC);":[12],"tumors":[13],"homologous":[15],"recombination":[16],"repair":[17],"(HRR)":[18],"defects":[19,33],"particularly":[21],"sensitive":[22,102],"to":[23,36,72,113,169],"this":[24,54],"drug":[25,51,86],"class.":[26],"While":[27],"previous":[28],"work":[29],"has":[30],"associated":[31],"ATM":[32],"response":[35,112,172],"PARPi,":[37],"its":[38],"predictive":[39],"value":[40],"remains":[41],"controversial":[42],"and":[43,48,74,81,85,104,116,163,173],"the":[44,95,110,121,130],"mechanisms":[45],"underlying":[46],"sensitivity":[47,87,139,159],"eventual":[49],"acquired":[50,69],"resistance":[52,71],"in":[53,63,101,127,134,160],"setting":[55],"remain":[56],"unclear.":[57],"To":[58],"address":[59],"this,":[60],"we":[61,125],"generated":[62],"vitro":[64],"models":[67,93,136],"of":[68,132,157],"PARPi":[70,100,158],"olaparib":[73],"saruparib,":[75],"a":[76,106,154,165],"novel":[77],"selective":[78],"PARP1":[79],"inhibitor":[80],"pursued":[82],"functional":[83],"characterization":[84],"studies.":[88],"We":[89],"found":[90],"that":[91,129],"resistant":[92,135],"bypass":[94],"G2/M":[96],"arrest":[97],"induced":[98],"by":[99],"models;":[103],"display":[105],"greater":[107],"reliance":[108],"on":[109],"ATR-dependent":[111],"DNA":[114],"damage":[115],"replication":[117,142],"stress,":[118],"mainly":[119],"through":[120,140],"ATR-CHK1":[122],"axis.":[123],"Consistently,":[124],"demonstrate":[126],"vivo":[128],"combination":[131,168],"PARPi-ATRi":[133],"restores":[137],"treatment":[138,171],"enhancing":[141],"stress.":[143],"Collectively,":[144],"these":[145],"findings":[146],"highlight":[147],"an":[148],"interplay":[149],"between":[150],"ATM-ATR":[151],"signaling":[152],"as":[153],"key":[155],"mediator":[156],"ATM-deficient":[161],"mPC":[162],"identify":[164],"promising":[166],"therapeutic":[167],"prolong":[170],"potentially":[174],"improve":[175],"patients'":[176],"outcomes.":[177]},"counts_by_year":[{"year":2026,"cited_by_count":4}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-11-27T00:00:00"}